Sheldon Feldman, MD
Surgical Oncology · New York, NYNPI 1942283742
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $66,000 of the $97,299 with a category attached, or 67.8%. Stryker accounts for 85.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $51,222 and has fallen 71.6% since, to $14,566 in 2025. Among surgical oncology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 58 payments — averaging $1677.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$83K
- Impedimed, Inc.$13K
- Dilon Technologies, Inc.$132
- Carl Zeiss Meditec USA, Inc.$118
- Endomagnetics Ltd$95
- Carl Zeiss Meditec, Inc.$56
What the payments were for
- Consulting fees$66,00068%
- Speaking & faculty fees$9,87510%
- Travel & lodging$17,01517%
- Food & beverage$4,4085%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 48 | $83,451 |
| Impedimed, Inc. | 6 | $13,449 |
| Dilon Technologies, Inc. | 1 | $132 |
| Carl Zeiss Meditec USA, Inc. | 1 | $118 |
| Endomagnetics Ltd | 1 | $95 |
| Carl Zeiss Meditec, Inc. | 1 | $56 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPY-PHI SYSTEM$53,965
- MOLLI$30,400
- 1788$26,291
- 1688$11,746
- NA$7,600
- DERMACELL$7,600
- PHOTONBLADE$2,400
- AIM LAPARASCOPES$200
- SURG - ANESTHESIA$147
- HemoBlast Bellows$132
- EIKON LT$124
- INTRABEAM$118
- IORT$118
How this compares
$97,299 in reported general payments places this provider in the 95th percentile of 173 surgical oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in New York
- Kepal PatelNew York$94K
- George PlitasNew York$39K
- James ParkNew York$28K
- Michael LoweNew York$20K
- Scott HananNew York$15K
- Marcovalerio MelisNew York$12K
- Kevin SoaresNew York$10K
- Jennifer CracchioloNew York$9K
- Bert PetersenNew York$7K
- Paul SchmidtNew York$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.